Form 8-K - Current report:
SEC Accession No. 0001558370-25-000291
Filing Date
2025-01-21
Accepted
2025-01-21 17:09:06
Documents
58
Period of Report
2025-01-21
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xlo-20250121x8k.htm   iXBRL 8-K 55861
2 EX-99.1 xlo-20250121xex99d1.htm EX-99.1 74798
3 EX-99.2 xlo-20250121xex99d2.htm EX-99.2 35981
4 GRAPHIC xlo-20250121xex99d1g001.jpg GRAPHIC 64090
5 GRAPHIC xlo-20250121xex99d1g002.jpg GRAPHIC 256719
6 GRAPHIC xlo-20250121xex99d1g003.jpg GRAPHIC 98416
7 GRAPHIC xlo-20250121xex99d1g004.jpg GRAPHIC 176097
8 GRAPHIC xlo-20250121xex99d1g005.jpg GRAPHIC 138084
9 GRAPHIC xlo-20250121xex99d1g006.jpg GRAPHIC 88536
10 GRAPHIC xlo-20250121xex99d1g007.jpg GRAPHIC 95917
11 GRAPHIC xlo-20250121xex99d1g008.jpg GRAPHIC 154655
12 GRAPHIC xlo-20250121xex99d1g009.jpg GRAPHIC 133667
13 GRAPHIC xlo-20250121xex99d1g010.jpg GRAPHIC 165440
14 GRAPHIC xlo-20250121xex99d1g011.jpg GRAPHIC 59946
15 GRAPHIC xlo-20250121xex99d1g012.jpg GRAPHIC 94550
16 GRAPHIC xlo-20250121xex99d1g013.jpg GRAPHIC 133068
17 GRAPHIC xlo-20250121xex99d1g014.jpg GRAPHIC 137325
18 GRAPHIC xlo-20250121xex99d1g015.jpg GRAPHIC 107545
19 GRAPHIC xlo-20250121xex99d1g016.jpg GRAPHIC 92345
20 GRAPHIC xlo-20250121xex99d1g017.jpg GRAPHIC 90326
21 GRAPHIC xlo-20250121xex99d1g018.jpg GRAPHIC 149442
22 GRAPHIC xlo-20250121xex99d1g019.jpg GRAPHIC 164076
23 GRAPHIC xlo-20250121xex99d1g020.jpg GRAPHIC 119678
24 GRAPHIC xlo-20250121xex99d1g021.jpg GRAPHIC 106562
25 GRAPHIC xlo-20250121xex99d1g022.jpg GRAPHIC 165178
26 GRAPHIC xlo-20250121xex99d1g023.jpg GRAPHIC 86936
27 GRAPHIC xlo-20250121xex99d1g024.jpg GRAPHIC 116427
28 GRAPHIC xlo-20250121xex99d1g025.jpg GRAPHIC 135138
29 GRAPHIC xlo-20250121xex99d1g026.jpg GRAPHIC 165285
30 GRAPHIC xlo-20250121xex99d1g027.jpg GRAPHIC 86566
31 GRAPHIC xlo-20250121xex99d1g028.jpg GRAPHIC 104689
32 GRAPHIC xlo-20250121xex99d1g029.jpg GRAPHIC 124933
33 GRAPHIC xlo-20250121xex99d1g030.jpg GRAPHIC 111490
34 GRAPHIC xlo-20250121xex99d1g031.jpg GRAPHIC 129222
35 GRAPHIC xlo-20250121xex99d1g032.jpg GRAPHIC 135190
36 GRAPHIC xlo-20250121xex99d1g033.jpg GRAPHIC 146508
37 GRAPHIC xlo-20250121xex99d1g034.jpg GRAPHIC 121989
38 GRAPHIC xlo-20250121xex99d1g035.jpg GRAPHIC 98047
39 GRAPHIC xlo-20250121xex99d1g036.jpg GRAPHIC 119216
40 GRAPHIC xlo-20250121xex99d1g037.jpg GRAPHIC 113609
41 GRAPHIC xlo-20250121xex99d1g038.jpg GRAPHIC 122894
42 GRAPHIC xlo-20250121xex99d1g039.jpg GRAPHIC 113918
43 GRAPHIC xlo-20250121xex99d1g040.jpg GRAPHIC 122079
44 GRAPHIC xlo-20250121xex99d1g041.jpg GRAPHIC 91229
45 GRAPHIC xlo-20250121xex99d1g042.jpg GRAPHIC 106884
46 GRAPHIC xlo-20250121xex99d1g043.jpg GRAPHIC 86550
  Complete submission text file 0001558370-25-000291.txt   7457832

Data Files

Seq Description Document Type Size
47 EX-101.SCH xlo-20250121.xsd EX-101.SCH 3404
48 EX-101.LAB xlo-20250121_lab.xml EX-101.LAB 16580
49 EX-101.PRE xlo-20250121_pre.xml EX-101.PRE 10710
60 EXTRACTED XBRL INSTANCE DOCUMENT xlo-20250121x8k_htm.xml XML 5045
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)

EIN.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40925 | Film No.: 25543250
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)